Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

NEUROSTIMULATION - A GLOBAL MARKET REPORT   

Research Abstract

This report analyzes the Global markets for Neurostimulation in US$ Million by the following Product Segments: Spinal Cord Stimulators (SCS) {Radio Frequency (RF) System, Implantable Pulse Generator (IPG)}, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), and Vagus Nerve Stimulators (VNS). In addition to the above listed product segments, the report analyzes the US market for Neurostimulation by Gastric Electric Stimulators (GES). The report provides separate comprehensive analytics for the US, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets .The report profiles 29 companies including many key and niche players such as Afferent Corp., Boston Scientific Corp., Cyberkinetics Neurotechnology Systems, Inc., Cyberonics, Inc., Medtronic, Inc., St. Jude Medical, Inc., and Synapse Biomedical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1227
Price : $4500
Companies : 29
Pages : 185
Date : September 2010
Market Data Tables : 50

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  NEUROSTIMULATION (Complete Report) Pages : 185   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.....I-15 $295  
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2  
   Data Interpretation & Reporting Level.....I-3
Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Spinal Cord Stimulation (SCS).....I-4
Radio Frequency (RF) Systems.....I-4
Implantable Pulse Generator Systems (IPGs).....I-4
Deep Brain Stimulation (DBS).....I-4
Sacral Nerve Stimulation (SNS).....I-4
  
   Vagus Nerve Stimulation (VNS).....I-5  
  2. MARKET SNAPSHOTS.....II-61 $100  
   Market Snapshots.....II-61$100
  3. MARKET OVERVIEW.....II-75 $495  
   Rising Demand for Neurostimulation Devices.....II-71$100
   Current and Future Analysis.....II-8 1$100
   Table 1: Worldwide Neurostimulation Market (2007-2015): Product Segments (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, and Vagus Nerve Stimulators) Ranked by Growth (includes corresponding Graph/Chart).....II-9
Neurostimulation Therapy Gets Popular.....II-9
1$350
   Technological Advancements So Far.....II-10
SCS - The New Painkiller.....II-10
Future Prospects.....II-10
1$100
   Obesity Control to Spur Market Growth in Future.....II-111$100
  4. TRENDS AND ISSUES.....II-124 $295  
   Chip Makers Struggle to Meet Quality Demand.....II-12
Market Growth Attracts New Investors.....II-12
Neurostimulation on a Rise with Growing Indications.....II-12
Neurostimulation Market Marked by High Entry Barriers.....II-12
1$100
   Increasing Acceptance of Neurostimulation due to Advanced Clinical Benefits.....II-13
Powering Neurostimulation Devices-The Key to Success.....II-13
1$100
   Market Development Initiatives to Fuel Market Growth.....II-14
Exploring Market Opportunities – The Technology Way.....II-14
Neurostimulation Devices – Growing Awareness and Acceptance Among Physicians.....II-14
1$100
   Synergy with Pharma & Biotech Companies Creates New Avenues.....II-15
Third-Party Reimbursement – A Vital Role to Play.....II-15
1$100
  5. COMPETITIVE SCENARIO.....II-164 $495  
   Few Players Dominate Neurostimulation Market.....II-16
Worldwide Neurostimulation Market: Leading Players by Product Segment.....II-16
1$100
   Table 2: Leading Players in the Global Neurostimulation Market (2009E): Percentage Share Breakdown of Value Sales for Medtronic, St. Jude Medical, Boston Scientific, Cyberonics and Others (includes corresponding Graph/Chart).....II-17

Table 3: World Neurostimulation Market (2009): Percentage Share Breakdown of Value Sales for Pain, Deafness, Epilepsy, Movement Disorders, Depression, Stroke, Incontinence, Gastroparesis and Obesity (includes corresponding Graph/Chart).....II-17
1$350
   Product Offerings of Leading Players in the Neurostimulation Market.....II-18
Select Spinal Cord Stimulation Product Offerings of St. Jude and Medtronic.....II-18
1$100
   Stimulation Parameters of Select SCS Products.....II-19
Companies Researching Neurostimulator Applications by Indication.....II-19
1$100
  6. NEUROMODULATION INDUSTRY: AN INSIGHT.....II-202 $200  
   Attacking the Source of Pain - The Logic behind Neuromodulation.....II-20
Growth Prospects for Neuromodulation Industry.....II-20
2$200
  7. PRODUCT OVERVIEW.....II-229 $595  
   Introduction to Neurostimulator.....II-22
A Historical Note.....II-22
1$100
   Neurostimulation Devices by Product Segment.....II-23
Spinal Cord Stimulation (SCS).....II-23
1$100
   SCS – What it Treats .....II-24
Segmentation by Type of Power Source.....II-24
Implantable Pulse Generator Systems (IPGs).....II-24
1$100
   Radio Frequency (RF) Systems.....II-25
Market Assessment for RF Systems.....II-25
Sacral Nerve Stimulation (SNS).....II-25
1$100
   Deep Brain Stimulation (DBS).....II-26
Vagus Nerve Stimulation (VNS).....II-26
1$100
   Gastric Electric Stimulation (GES).....II-27
Stimulation Device – How it Works .....II-27
1$100
   Neurostimulation & its Benefits.....II-28
Prospective Application Areas for Neurostimulators – Select Indications.....II-28
1$100
   Neurostimulation Indications and Use of Related Devices/Techniques in the US.....II-29
Approved Indications for Spinal Cord Stimulation by Geographic Regions.....II-29
1$100
   Neurostimulation Devices – Technology & Safety Issues.....II-301$100
  8. RECENT INDUSTRY ACTIVITY.....II-3113 $950  
   Sonova Holding Acquires Advanced Bionics.....II-31
NeuroMetrix Purchases Select Assets of Cyberkinetics Neurotechnology Systems.....II-31
St. Jude Medical Purchases Non-Cash Assets and Intellectual Property of Northstar
  Neuroscience.....II-31
1$100
   Victhom Human Bionics Signs Agreement with Otto Bock HealthCare.....II-32
Neuros Medical Collaborates with Battelle.....II-32
JumpStart & CTV Invest in Neuros Medical.....II-32
1$100
   InterWest Invests in Autonomic Technologies.....II-33
MicroTransponder Finalizes Series A Funding Round for Wireless Neurostimulator
  Development.....II-33
NDI Medical Divests MEDSTIM Device to Medtronic.....II-33
1$100
   Cyberkinetics Neurotechnology Systems and NeuroMetrix Enters into Joint Venture
  Agreement.....II-34
Greatbatch Takes Over Quan Emerteq.....II-34
RS Medical Takes Over CFS Medical.....II-34
1$100
   Cyberkinetics and Neurometrix Form Joint Venture to Develop Andara™ OFS™.....II-35
St. Jude Bags CE Mark and FDA Approvals for Eon Mini™.....II-35
St. Jude Medical Initiates Clinical Study of DBS.....II-35
1$100
   ANS Bags CE Mark Approval for Rapid Programmer 3.0.....II-36
Northstar Completes Trial of Renova-ST™.....II-36
Greatbatch Acquires Enpath Medical.....II-36
Critical Therapeutics Grants Global License to Innovative Metabolics.....II-36
1$100
   Biomet Merges with LVB Acquisition.....II-37
US Patent and Trademark Office Issues Cyberkinetics' Patent for Andara™OFS™
  Therapy.....II-37
Cyberonics Licenses Obesity-Related Patents.....II-37
1$100
   Stryker Invests in Afferent Corp.....II-38
Medtronic Receives PMA Approval for Specify™ 5-6-5 Surgical Lead.....II-38
BioControl Initiates CardioFit™ System’s Trials.....II-38
Medtronic Initiates Post-Market Study of InterStim™.....II-38
Cyberkinetics Successfully Tests Andara™OFS™ System.....II-38
Medtronic Completes Implants in SANTE Trial of Deep Brain Stimulation.....II-38
1$100
   Cyberonics Receives US FDA Approval for Demipulse™ and Demipulse Duo™.....II-39
Cyberonics Signs Licensing Agreement with Ethicon Endo-Surgery.....II-39
AMS Acquires Implantable Electrical Stimulation Platform Technology from
  BioControl.....II-39
Medtronic Bags FDA Approval on Interstim®.....II-39
1$100
   Boston’s Precision SCS System Successfully Implanted.....II-40
New Computer System to Improve Efficiency of Deep Brain Stimulation.....II-40
Cyberonics Bags FDA Approval for VNS Therapy System Labeling Format.....II-40
Impulse Dynamics Sponsors Study to Evaluate Optimizer.....II-40
Medtronic to Pursue Major Clinical Trial of DBS.....II-40
Cyberonics Bags FDA Real-Time Review Approval for Perennia™ Lead.....II-40
1$100
   Northstar Chooses AMI Semiconductor.....II-41
American Medical Acquires Technology License from BioControl Medical.....II-41
American Medical Systems Holdings Takes Over the Urology Unit of MedImpulse.....II-41
1$100
   Cyberkinetics Acquires Andara.....II-42
Cyberkinetics Pacts with Minnetronix.....II-42
Symphony Medical Strikes Deal with NDI Medical.....II-42
NDI Opens New Business Unit.....II-42
BRCP Funds Case to Extend Research Capabilities of ONNP.....II-42
ANS Receives Clearance on Eon for European Market.....II-42
1$100
   Medtronic Receives FDA Nod for RestorePRIME.....II-43
Boston Scientific Implants PRISM.....II-43
Neuroscience Bags FDA Approval on P-Stim™.....II-43
Victhom Receives Patents from USPTO.....II-43
1$100
  9. PRODUCT INNOVATIONS/INTRODUCTIONS.....II-4410 $950  
   Medtronic Unveils Brain Stimulation Products.....II-44
Alphalife Launches Alpha Brainwave Neurostimulator.....II-44
ImThera Medical Introduces aura6000™ Neurostimulation System.....II-44
St. Jude Receives Approval for Neurostimulation System from Japanese MHLW.....II-44
1$100
   St. Jude Secures European CE Mark Approval for Epiducer™ Lead Delivery System.....II-45
St. Jude Medical Obtains TGA Approval for Brio™ DBS System.....II-45
Boston Scientific Secures FDA Approval for D4 and W4 SCS Lead Splitters.....II-45
1$100
   Mobilis Healthcare Introduces InterX.....II-46
IMEC Develops and Models New Design for Brain Stimulation Implants.....II-46
St. Jude Medical Receives Approval for Penta Neurostimulation Lead from FDA.....II-46
1$100
   St. Jude Receives European CE Mark Approval for LibraXP™ and Libra® Deep Brain
  Stimulation Systems.....II-47
Medtronic Receives FDA Approval for Activa PC and Activa RC DBS Devices.....II-47
Medtronic Receives FDA Approval for Reclaim™ Deep Brain Stimulation Therapy.....II-47
St. Jude Receives European CE Mark Approval for Genesis® Neurostimulation
  System.....II-47
1$100
   St. Jude Eon Mini™ Neurostimulator Receives Australian Therapeutic Goods Administration
  Approval.....II-48
Medtronic Receives FDA Approval for Activa® RC, Activa PC DBS Devices.....II-48
1$100
   Medtronic Gains FDA Approval for RestoreULTRA™ Neurostimulator.....II-49
St. Jude Receives European CE Mark and FDA Approval for EonC™.....II-49
St. Jude Receives Battery Longevity Approval from European CE Mark and FDA for
  Eon®.....II-49
1$100
   Medtronic Delivers Procedural Intelligence in StealthStation® System.....II-50
Medtronic Unveils Patient Referral Advisor Software in US .....II-50
Boston Scientific Introduces Smallest Rechargeable SCS System.....II-50
1$100
   Tennessee Inventors Develops Apparatus of Deep Brain Stimulator.....II-51
California Inventors Develop IPG.....II-51
Medtronic Rolls Out Two ImplanTable Neurostimulation Systems.....II-51
Medtronic Introduces Two Latest Neurostimulation Systems.....II-51
1$100
   Neuroscience Therapy Launches P-Stim Electro Stimulation Device.....II-52
NeuroPace and AMI Semiconductor Develops ImplanTableEpilepsy Device .....II-52
Neuroscience Launches P-Stim™.....II-52
1$100
   AMI Semiconductor to Develop ASIC for New Stroke Therapy.....II-53
Medtronic Unveils Two New Neurostimulation Systems.....II-53
ANS Launches Rapid Programmer 3.0.....II-53
1$100
  10. FOCUS ON SELECT PLAYERS.....II-543 $295  
   Afferent Corp. (USA).....II-54
Boston Scientific Corp. (USA).....II-54
Cyberkinetics Neurotechnology Systems, Inc. (USA).....II-54
1$100
   Cyberonics, Inc. (USA).....II-55
Medtronic, Inc. (USA).....II-55
1$100
   St. Jude Medical, Inc. (USA).....II-56
Synapse Biomedical, Inc. (USA).....II-56
1$100
  11. GLOBAL MARKET PERSPECTIVE.....II-57   
   Table 4: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-571$350
   Table 5: World Historic Review for Neurostimulation by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-58

Table 6: World 11-Year Perspective for Neurostimulation by Geographic Region – Percentage Breakdown of Value Sales for US and Rest of World Markets for the Years 2005, 2010 and 2015.....II-58
1$350
   Table 7: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-59

Table 8: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-59
1$350
   Table 9: World Historic Review for Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-60

Table 10: World Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-60
1$350
   Table 11: World 11-Year Perspective for Spinal Cord Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015.....II-61

Table 12: World 11-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015.....II-61
1$350
   Table 13: World Recent Past, Current & Future Analysis for Radio Frequency Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-62

Table 14: World Historic Review for Radio Frequency Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-62
1$350
   Table 15: World 11-Year Perspective for Radio Frequency Spinal Cord Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015.....II-631$350
   Table 16: World Recent Past, Current & Future Analysis for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-64

Table 17: World Historic Review for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-64
1$350
   Table 18: World 11-Year Perspective for Implantable Pulse Generator (IPG) Spinal Cord Stimulators by Geographic Region – Percentage Breakdown of Value Sales for US and Rest of World Markets for the Years 2005, 2010 and 2015.....II-651$350
   Table 19: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-66

Table 20: World Historic Review for Deep Brain Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-66
1$350
   Table 21: World 11-Year Perspective for Deep Brain Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015.....II-671$350
   Table 22: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-68

Table 23: World Historic Review for Sacral Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-68
1$350
   Table 24: World 11-Year Perspective for Sacral Nerve Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015.....II-691$350
   Table 25: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2007 through 2015 (includes corresponding Graph/Chart).....II-70

Table 26: World Historic Review for Vagus Nerve Stimulators by Geographic Region – US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2000 through 2006 (includes corresponding Graph/Chart).....II-70
1$350
   Table 27: World 11-Year Perspective for Vagus Nerve Stimulators by Geographic Region – Percentage Breakdown of Value Sales for United States and Rest of the World Markets for the Years 2005, 2010 and 2015.....II-711$350
  12. THE UNITED STATES.....II-7217 $2950  
   A. Market Analysis.....II-72
Overview.....II-72
Neurostimulation Products Market to Witness Growth.....II-72
1$100
   Product Segments Ranked by Growth.....II-73
Table 28: Neurostimulation Market in the US (2007-2015): Product Segments (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES)) Ranked by Growth in Volume Sales (includes corresponding Graph/Chart).....II-73
1$350
   Table 29: Neurostimulation Market in the US (2007-2015): Product Segments (SpinalCord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES)) Ranked by Growth in Value Sales (includes corresponding Graph/Chart).....II-74

Table 30: Neurostimulation Market in the US (2010): Unit Sales & Percentage Breakdown by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart).....II-74
1$350
   Table 31: Neurostimulation Market in the US (2010): Value Sales (in US$ Million) & Percentage Market Share by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS) and Gastric Electric Stimulators (GES) (includes corresponding Graph/Chart).....II-75
Potential Growth for Neurostimulation Systems in the US.....II-75
Spinal Cord Stimulation Products Market.....II-75
1$350
   Sacral Nerve Stimulation Products Market.....II-761$100
   Deep Brain Stimulation Products Market.....II-77
Shift Away from Orthopaedic and Cardiovascular Device Markets.....II-77
1$100
   Trends in the Embolotherapy Market.....II-78
Neurovascular Stents Market Attracting Cardiovascular Companies.....II-78
1$100
   Migraine Devices – New Frontiers for Neurostimulation.....II-79
Competitive Landscape.....II-79
1$100
   Table 32: Leading Players in the US Neurostimulation Market (2009E): Percentage Breakdown of Revenues for Medtronic, Advanced Bionics, St. Jude Medical, Cyberonics and Others (includes corresponding Graph/Chart).....II-80
B. Market Analytics.....II-80
Table 33: US Recent Past, Current & Future Analysis for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-80
1$350
   Table 34: US Recent Past, Current & Future Analysis for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-811$350
   Table 35: US Historic Review for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2000 through 2006 (includes corresponding Graph/Chart).....II-821$350
   Table 36: US Historic Review for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).....II-831$350
   Table 37: US 11-Year Perspective for Neurostimulators by Product Segment – Percentage Breakdown of Unit Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2005, 2010 and 2015 (includes corresponding Graph/Chart).....II-841$350
   Table 38: US 11-Year Perspective for Neurostimulators by Product Segment – Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2005, 2010 and 2015 (includes corresponding Graph/Chart).....II-851$350
   Table 39: US Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-86

Table 40: US Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-86
1$350
   Table 41: US Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in Units for Years 2000 through 2006 (includes corresponding Graph/Chart).....II-87

Table 42: US Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).....II-87
1$350
   Table 43: US 11-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Unit Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015.....II-88

Table 44: US 11-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015.....II-88
1$350
  13. REST OF WORLD.....II-895 $1450  
   A. Market Analysis.....II-89
Outlook.....II-89
B. Market Analytics.....II-89
Table 45: Rest of World Recent Past, Current & Future Analysis for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-89
1$350
   Table 46: Rest of World Historic Review for Neurostimulators by Product Segment – Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).....II-901$350
   Table 47: Rest of World 11-Year Perspective for Neurostimulators by Product Segment – Percentage Breakdown of Value Sales for Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES) Markets for the Years 2005, 2010 and 2015 (includes corresponding Graph/Chart).....II-911$350
   Table 48: Rest of World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-921$350
   Table 49: Rest of World Historic Review for Spinal Cord Stimulators by Product Segment – Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).....II-93

Table 50: Rest of World 11-Year Perspective for Spinal Cord Stimulators by Product Segment – Percentage Breakdown of Value Sales for Radio Frequency (RF) System and Implantable Pulse Generator (IPG) Markets for the Years 2005, 2010 and 2015.....II-93
1$350
COMPETITION 84$995
  
Total Companies Profiled: 29 (including Divisions/Subsidiaries - 33)

Region/Country                 Players


The United States                 25   
Canada                             1
Europe                             6
     The United Kingdom            2
     Rest of Europe                4
Asia-Pacific (Excluding Japan)     1
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign